Looking at the steady northward pathway of the system that bulls have been pushing in the exchange lines of Skinbiotherapeutics Plc (LSE:SBTX), it is likely that the stock market may face a retrace at 25 points soon, given that it reaches a peak.
The price movements, reflected in a series of bullish candlesticks, suggest that buyers have largely exhausted their upward momentum, struggling to maintain positions above the moving average indicators. This could signal a potential deviation from established technical principles, indicating a higher risk of price reversal or consolidation.
Resistance Levels: 27.5, 30, 32.5
Support Levels: 20, 17.5, 15
Judging by the postures of the indicators, will the SBTX Plc stock see logical longing entries above the EMAs subsequently?
As it stands, if the bears’ responses do not produce a series of selling candlesticks around the current trade level, the subsequent price actions could trigger a consolidation phase, especially if Skinbiotherapeutics Plc shares reach a peak and are likely to retrace around the 25-point level.
The trend line of the 15-day EMA is positioned above the 50-day EMA, both trending northward across the 20 level with close proximity. As of the latest data, the stochastic oscillators have moved northward into the overbought region, signaling that buying momentum has reached a critical juncture—either poised for a brief consolidation or facing a potential reversal.
Learn from market wizards: Books to take your trading to the next